Jundishapur Journal of Microbiology

Published by: Kowsar

8-Hydroxy-2'-Deoxyguanosin in Peripheral Leukocyte Associated With HBsAg in Patients with Chronic Hepatitis B

Ashraf Mohamadkhani 1 , * , Samaneh Moafi 1 , Hamid Reza Fazli 1 , Samaneh Mirzaei 1 , Maryam Sharafkhah 1 , 2 , Sima Besharat 3 , Ghodratollah Montazeri 1 and Hossein Poustchi 1
Authors Information
1 Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, IR Iran
2 Department of Epidemiology and Biostatistics, Tehran University of Medical Sciences, Tehran, IR Iran
3 Golestan Research Center of Gastroentrology and Hepatology, Golestan University of Medical Sciences, Gorgan, IR Iran
Article information
  • Jundishapur Journal of Microbiology: May 2017, 10 (5); e42609
  • Published Online: January 31, 2017
  • Article Type: Research Article
  • Received: September 27, 2016
  • Revised: January 14, 2017
  • Accepted: January 24, 2017
  • DOI: 10.5812/jjm.42609

To Cite: Mohamadkhani A, Moafi S, Fazli H R, Mirzaei S, Sharafkhah M, et al. 8-Hydroxy-2'-Deoxyguanosin in Peripheral Leukocyte Associated With HBsAg in Patients with Chronic Hepatitis B, Jundishapur J Microbiol. 2017 ; 10(5):e42609. doi: 10.5812/jjm.42609.

Abstract
Copyright © 2017, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnote
References
  • 1. Mahoney FJ. Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin Microbiol Rev. 1999; 12(2): 351-66[PubMed]
  • 2. Clippinger AJ, Bouchard MJ. Hepatitis B virus HBx protein localizes to mitochondria in primary rat hepatocytes and modulates mitochondrial membrane potential. J Virol. 2008; 82(14): 6798-811[DOI][PubMed]
  • 3. Besharat S, Katoonizadeh A, Moossavi S, Darvishi Z, Roshandel G, Poustchi H, et al. The possible impact of sortilin in reducing HBsAg expression in chronic hepatitis B. J Med Virol. 2016; 88(4): 647-52[DOI][PubMed]
  • 4. Xia W, Shen Y, Xie H, Zheng S. Involvement of endoplasmic reticulum in hepatitis B virus replication. Virus Res. 2006; 121(2): 116-21[DOI][PubMed]
  • 5. Xu Z, Jensen G, Yen TS. Activation of hepatitis B virus S promoter by the viral large surface protein via induction of stress in the endoplasmic reticulum. J Virol. 1997; 71(10): 7387-92[PubMed]
  • 6. Mohamadkhani A, Montazeri G, Poustchi H. The importance of hepatitis B virus genome diversity in Basal core promoter region. Middle East J Dig Dis. 2011; 3(1): 13-9[PubMed]
  • 7. Boltjes A, Movita D, Boonstra A, Woltman AM. The role of Kupffer cells in hepatitis B and hepatitis C virus infections. J Hepatol. 2014; 61(3): 660-71[DOI][PubMed]
  • 8. Mohamadkhani A, Jazii FR, Sayehmiri K, Jafari-Nejad S, Montaser-Kouhsari L, Poustchi H, et al. Plasma myeloperoxidase activity and apolipoprotein A-1 expression in chronic hepatitis B patients. Arch Iran Med. 2011; 14(4): 254-8[PubMed]
  • 9. Mohamadkhani A, Bastani F, Khorrami S, Ghanbari R, Eghtesad S, Sharafkhah M, et al. Negative Association of Plasma Levels of Vitamin D and miR-378 With Viral Load in Patients With Chronic Hepatitis B Infection. Hepat Mon. 2015; 15(6)[DOI][PubMed]
  • 10. Ames BN, Saul RL. Oxidative DNA damage as related to cancer and aging. Prog Clin Biol Res. 1986; 209A: 11-26[PubMed]
  • 11. Dandri M, Burda MR, Burkle A, Zuckerman DM, Will H, Rogler CE, et al. Increase in de novo HBV DNA integrations in response to oxidative DNA damage or inhibition of poly(ADP-ribosyl)ation. Hepatology. 2002; 35(1): 217-23[DOI][PubMed]
  • 12. Shimoda R, Nagashima M, Sakamoto M, Yamaguchi N, Hirohashi S, Yokota J, et al. Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis. Cancer Res. 1994; 54(12): 3171-2[PubMed]
  • 13. Reddy MV, Randerath K. Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis. 1986; 7(9): 1543-51[PubMed]
  • 14. Lok AS, McMahon BJ. [AASLD Practice Guidelines. Chronic hepatitis B: update of therapeutic guidelines]. Rom J Gastroenterol. 2004; 13(2): 150-4[PubMed]
  • 15. Mohamadkhani A, Poustchi H. Repository of Human Blood Derivative Biospecimens in Biobank: Technical Implications. Middle East J Dig Dis. 2015; 7(2): 61-8[PubMed]
  • 16. Peluso M, Hainaut P, Airoldi L, Autrup H, Dunning A, Garte S, et al. Methodology of laboratory measurements in prospective studies on gene-environment interactions: the experience of GenAir. Mutat Res. 2005; 574(1-2): 92-104[PubMed]
  • 17. Hsieh YH, Su IJ, Wang HC, Chang WW, Lei HY, Lai MD, et al. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis. 2004; 25(10): 2023-32[DOI][PubMed]
  • 18. Srisuttee R, Koh SS, Park EH, Cho IR, Min HJ, Jhun BH, et al. Up-regulation of Foxo4 mediated by hepatitis B virus X protein confers resistance to oxidative stress-induced cell death. Int J Mol Med. 2011; 28(2): 255-60[DOI][PubMed]
  • 19. Mohamadkhani A, Shahnazari P, Minuchehr Z, Madadkar-Sobhani A, Tehrani MJ, Jazii FR, et al. Protein-x of hepatitis B virus in interaction with CCAAT/enhancer-binding protein alpha (C/EBPalpha)--an in silico analysis approach. Theor Biol Med Model. 2011; 8: 41[DOI][PubMed]
  • 20. Parola M, Robino G. Oxidative stress-related molecules and liver fibrosis. J Hepatol. 2001; 35(2): 297-306[PubMed]
  • 21. Mohamadkhani A, Naderi E, Sotoudeh M, Katoonizadeh A, Montazeri G, Poustchi H. Clinical feature of intrahepatic B-lymphocytes in chronic hepatitis B. Int J Inflam. 2014; 2014: 896864[DOI][PubMed]
  • 22. Moossavi S, Besharat S, Sharafkhah M, Ghanbari R, Sharifi A, Rezanejad P, et al. Inverse Association of Plasma Level of Glutathione Peroxidase with Liver Fibrosis in Chronic Hepatitis B: Potential Role of Iron. Middle East J Dig Dis. 2016; 8(2): 122-30[DOI][PubMed]
  • 23. Fujita N, Sugimoto R, Ma N, Tanaka H, Iwasa M, Kobayashi Y, et al. Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C. J Viral Hepat. 2008; 15(7): 498-507[DOI][PubMed]
  • 24. Farinati F, Cardin R, Degan P, De Maria N, Floyd RA, Van Thiel DH, et al. Oxidative DNA damage in circulating leukocytes occurs as an early event in chronic HCV infection. Free Radic Biol Med. 1999; 27(11-12): 1284-91[PubMed]
  • 25. Tanaka S, Miyanishi K, Kobune M, Kawano Y, Hoki T, Kubo T, et al. Increased hepatic oxidative DNA damage in patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma. J Gastroenterol. 2013; 48(11): 1249-58[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments